The clinical significance of this EV-mediated delivery of the plasminogen system is underscored by the identification of uPAR+ extracellular vesicles as robust biomarkers for metastatic disease [156] and by the correlation of exosomal PAI-1 levels with tumor progression and immune evasion [157,158]. Here, PLG is linked to neoplasm.